What's next for Novo Nordisk's anti-obesity drug CagriSema?

A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…

Pfizer executives discuss anti-obesity drug Metsera

Albert Bourla, chairman and CEO of Pfizer, speaks at the Wall Street Journal's Future of Everything festival in New York…